Product logins

Find logins to all Clarivate products below.


Juliane Ray

General Manager, Commercial

Juliane Ray is the Global Head of Medtech Strategy at Clarivate. In this role, she connects people with intelligence, expertise and workflow tools to bring commercially successful treatments to patients faster and enable teams to make decisions with speed and confidence, from strategy through research and development and, ultimately, commercial execution.

Juliane has held several global leadership roles in the medical device and technology industries. She began her career in consulting at Deloitte and ZS Associates, where she collaborated with life sciences executives on commercial strategy. She spent more than 10 years leading marketing, strategy and operations teams at Cardiovascular Systems Inc (acquired by Abbott Vascular), American Medical Systems (acquired by Boson Scientific) and Landauer (acquired by Danaher) before joining Veeva as Vice President of Medtech Commercial Strategy in 2021 and joining Clarivate in 2024.

Juliane holds an MBA from the University of Virginia (Darden School of Business) and a BA in economics and international studies from Macalester College. She also serves as Board Chair at the Jungle, a nonprofit theater in her home city of Minneapolis, Minnesota.

Latest news

News February 3, 2026
Clarivate Webinar “Intelligence Amplified in the Age of AI” Highlights How Trusted, Proprietary Data Powers Next Generation Innovation

London, UK – February 3, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age…

News February 2, 2026
Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities

London, UK – February 2, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100…

News January 28, 2026
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026

London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025